4.6 Article

Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent In Vitro and In Vivo Efficacy

Journal

MOLECULES
Volume 24, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/molecules24102021

Keywords

(3-benzyl-5-hydroxyphenyl)carbamate; Mycobacterium tuberculosis; antitubercular activity

Funding

  1. National Natural Science Foundation of China [21772240]
  2. Chinese Academy of Science [YJKYYQ20170036]
  3. Guangzhou Science Technology and Innovation Commission [201707010210, 201604020019]
  4. Science and Technology Innovation Leader of Guangdong Province [2016TX03R095]

Ask authors/readers for more resources

A series of 3-amino-5-benzylphenol derivatives were designed and synthesized. Among them, (3-benzyl-5-hydroxyphenyl)carbamates were found to exert good inhibitory activity against M. tuberculosis H37Ra, H37Rv and clinically isolated multidrug-resistant M. tuberculosis strains (MIC = 0.625-6.25 g/mL). The privileged compounds 3i and 3l showed moderate cytotoxicity against cell line A549. Compound 3l also exhibited potent in vivo inhibitory activity on a mouse infection model via the oral administration. The results demonstrated 3-hydroxyphenylcarbamates as a class of new antitubercular agents with good potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available